Correlation Between Candel Therapeutics and XORTX Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Candel Therapeutics and XORTX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Candel Therapeutics and XORTX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Candel Therapeutics and XORTX Therapeutics, you can compare the effects of market volatilities on Candel Therapeutics and XORTX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Candel Therapeutics with a short position of XORTX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Candel Therapeutics and XORTX Therapeutics.

Diversification Opportunities for Candel Therapeutics and XORTX Therapeutics

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Candel and XORTX is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Candel Therapeutics and XORTX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XORTX Therapeutics and Candel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Candel Therapeutics are associated (or correlated) with XORTX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XORTX Therapeutics has no effect on the direction of Candel Therapeutics i.e., Candel Therapeutics and XORTX Therapeutics go up and down completely randomly.

Pair Corralation between Candel Therapeutics and XORTX Therapeutics

Given the investment horizon of 90 days Candel Therapeutics is expected to generate 1.53 times more return on investment than XORTX Therapeutics. However, Candel Therapeutics is 1.53 times more volatile than XORTX Therapeutics. It trades about 0.06 of its potential returns per unit of risk. XORTX Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  657.00  in Candel Therapeutics on September 12, 2024 and sell it today you would earn a total of  118.00  from holding Candel Therapeutics or generate 17.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Candel Therapeutics  vs.  XORTX Therapeutics

 Performance 
       Timeline  
Candel Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Candel Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Candel Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
XORTX Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XORTX Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Candel Therapeutics and XORTX Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Candel Therapeutics and XORTX Therapeutics

The main advantage of trading using opposite Candel Therapeutics and XORTX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Candel Therapeutics position performs unexpectedly, XORTX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XORTX Therapeutics will offset losses from the drop in XORTX Therapeutics' long position.
The idea behind Candel Therapeutics and XORTX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account